278 related articles for article (PubMed ID: 12513676)
1. Dialogue and collaboration: a personal view on laboratory animal welfare developments in general, and on ECVAM's first decade in particular.
Koëter HB
Altern Lab Anim; 2002 Dec; 30 Suppl 2():207-10. PubMed ID: 12513676
[TBL] [Abstract][Full Text] [Related]
2. The future of ECVAM: a personal perspective.
Balls M
Altern Lab Anim; 2002 Dec; 30 Suppl 2():239-41. PubMed ID: 12513683
[TBL] [Abstract][Full Text] [Related]
3. Collaboration between ZEBET, FRAME, and ECVAM: FRAME's contribution to establishing the Three Rs in Europe.
Spielmann H
Altern Lab Anim; 2009 Dec; 37 Suppl 2():23-7. PubMed ID: 20105007
[TBL] [Abstract][Full Text] [Related]
4. Alternatives to animal experiments: producing the fruits.
Balls M
Altern Lab Anim; 2002; 30(4):361-2. PubMed ID: 12234243
[No Abstract] [Full Text] [Related]
5. The Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM): a review of the ICCVAM test method evaluation process and current international collaborations with the European Centre for the Validation of Alternative Methods (ECVAM).
Stokes WS; Schechtman LM; Hill RN
Altern Lab Anim; 2002 Dec; 30 Suppl 2():23-32. PubMed ID: 12513648
[TBL] [Abstract][Full Text] [Related]
6. ECVAM'S activities in the EU candidate countries.
Sladowski D; Halder M
Altern Lab Anim; 2002 Dec; 30 Suppl 2():203-5. PubMed ID: 12513675
[TBL] [Abstract][Full Text] [Related]
7. The principles of validation and the ECVAM validation process.
Worth AP; Balls M
Altern Lab Anim; 2002 Dec; 30 Suppl 2():15-21. PubMed ID: 12513647
[TBL] [Abstract][Full Text] [Related]
8. Dialogue and collaboration with ECVAM: the view of the EFPIA.
Garthoff B
Altern Lab Anim; 2002 Dec; 30 Suppl 2():195-8. PubMed ID: 12513673
[TBL] [Abstract][Full Text] [Related]
9. The ECVAM workshops: a critical assessment of their impact on the development, validation and acceptance of alternative methods.
Combes RD
Altern Lab Anim; 2002 Dec; 30 Suppl 2():151-65. PubMed ID: 12513668
[TBL] [Abstract][Full Text] [Related]
10. Reduction of use of animals in regulatory genotoxicity testing: Identification and implementation opportunities-Report from an ECVAM workshop.
Pfuhler S; Kirkland D; Kasper P; Hayashi M; Vanparys P; Carmichael P; Dertinger S; Eastmond D; Elhajouji A; Krul C; Rothfuss A; Schoening G; Smith A; Speit G; Thomas C; van Benthem J; Corvi R
Mutat Res; 2009; 680(1-2):31-42. PubMed ID: 19765670
[TBL] [Abstract][Full Text] [Related]
11. Number of animals used for experimental purposes lower in the European Union.
von Aulock S
ALTEX; 2014; 31(1):1. PubMed ID: 24600696
[No Abstract] [Full Text] [Related]
12. Refinement, reduction, and replacement of animal use for regulatory testing: future improvements and implementation within the regulatory framework.
Richmond J
ILAR J; 2002; 43 Suppl():S63-8. PubMed ID: 12388854
[TBL] [Abstract][Full Text] [Related]
13. OECD Test Guidelines are tools, not blueprints, for chemical safety assessment.
Phillips B
Altern Lab Anim; 2006 Feb; 34(1):115-7. PubMed ID: 16522155
[No Abstract] [Full Text] [Related]
14. Lessons learned from validation of in vitro toxicity test: from failure to acceptance into regulatory practice.
Spielmann H; Liebsch M
Toxicol In Vitro; 2001; 15(4-5):585-90. PubMed ID: 11566595
[TBL] [Abstract][Full Text] [Related]
15. ECVAM: desperately needed or superfluous? An animal welfare perspective.
Kolar R
Altern Lab Anim; 2002 Dec; 30 Suppl 2():169-74. PubMed ID: 12513669
[TBL] [Abstract][Full Text] [Related]
16. ECVAM-ICCVAM: prospects for future collaboration.
Schechtman LM; Stokes WS
Altern Lab Anim; 2002 Dec; 30 Suppl 2():227-36. PubMed ID: 12513682
[TBL] [Abstract][Full Text] [Related]
17. Future activities: ECVAM and the quality control of biologicals.
Cussler K; Halder M; Hendriksen C
Altern Lab Anim; 2002 Dec; 30 Suppl 2():225-6. PubMed ID: 12513681
[TBL] [Abstract][Full Text] [Related]
18. FRAME Annual Lecture. International co-operation: an essential requirement for replacing animal toxicity tests.
Spielmann H
Altern Lab Anim; 2001; 29(6):637-46; discussion 647-8. PubMed ID: 11709040
[TBL] [Abstract][Full Text] [Related]
19. Opportunities for the government to actively promote the Three Rs during the UKs Presidency of the European Union (1 July to 31 December).
Combes R; Balls M
Altern Lab Anim; 2005 Aug; 33(4):317-21. PubMed ID: 16185102
[No Abstract] [Full Text] [Related]
20. ECVAM's response to the changing political environment for alternatives: consequences of the European Union chemicals and cosmetics policies.
Hartung T; Bremer S; Casati S; Coecke S; Corvi R; Fortaner S; Gribaldo L; Halder M; Roi AJ; Prieto P; Sabbioni E; Worth A; Zuang V
Altern Lab Anim; 2003 Nov; 31(5):473-81. PubMed ID: 15598174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
